Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic

To report experience with fecal microbiota transplantation (FMT) for recurrent Clostridioides difficile infection (rCDI) and provide recommendations for management of rCDI and donor testing during the COVID-19 pandemic.

Source: Mayo Clinic Proceedings - June 1, 2021 Category: Internal Medicine Authors: Sahil Khanna, Aaron Tande, David T. Rubin, Alexander Khoruts, Stacy A. Kahn, Darrell S. Pardi Tags: Original article Source Type: research